MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

Home » Google Glass startup gains funding for flagship product | Medtech funding stories for the week of Mar. 17, 2014

Google Glass startup gains funding for flagship product | Medtech funding stories for the week of Mar. 17, 2014

By

Augmedix raises $3.2M for Google Glass for docs

March 19, 2014 by Arezu Sarvestani

Augmedix raises $3.2M for Google Glass for docs

Augmedix calls itself the "first and largest Google Glass startup poised to revolutionize healthcare," touting a $3.2 million venture funding round and a move to a larger headquarters in San Francisco.

Now at 36 employees, the 2-year-old company is working on a flagship product that would free physicians from the “flood of data and documentation” they face on a regular basis. Augmedix’s service platform allows doctors to use Google Glass to push information to patient records and retrieve information verbally. Read more

Catheter maker Bi02 Medical raises $6M

March 14, 2014 by Brad Perriello

Catheter maker Bi02 Medical raises $6M

Bi02 Medical, maker of the Angel vena cava filter catheter, said it raised nearly $5.9 million in a hoped-for $7.5 million equity offering.

The funding round for the San Antonio, Texas-based medical device company involved 10 unnamed investors, according to a regulatory filing. Read more

OnTarget Labs lands $15M for tumor fluorescing tech

March 17, 2014 by Brad Perriello

OnTarget Labs lands $15M for tumor fluorescing tech

OnTarget Laboratories said it landed a $15 million investment from a pair of backers for its tumor-lighting technology developed at Purdue University by the founder of Endocyte.

The OnTarget technology uses small molecules and fluorescent dyes to target and illuminate specific cancerous cells, according to the West Lafayette, Ind.-based company’s website. It was developed by Philip Low, the Ralph Corley Distinguished Professor of Chemistry and director of the Center for Drug Discovery at Purdue University. Read more

Oculeve raises $16.6M in support of dry eye disease treatment

March 19, 2014 by Arezu Sarvestani

Oculeve raises $16.6M in support of dry eye disease treatment

San Francisco startup Oculeve Inc. closed a $16.6 million funding round in supports of its implantable technology for treatment of dry eye disease.

The money was raised through sales of equity to 8 unnamed investors, according to an SEC filing. Around this same time last year Oculeve had reported $7.6 million raised from 9 investors and in October 2012 the company reportedly raised $7.6 million from 8 investors. The company has reportedly raised around $33.2 million since 2011. Read more

Zimmer, Draeger and Altitude tally $234M in Pentagon supply deals

March 20, 2014 by Arezu Sarvestani

Zimmer, Draeger and Altitude tally $234M in Pentagon supply deals

A trio of medical device makers collected Pentagon supply deals worth a collective $234.3 million, according to recent Defense Dept. reports.

Medtech titan Zimmer landed a contract worth $65.6 million, the maximum possible extension under the company’s multi-year contract. The new deal represents the 3rd of 5 possible year-long extensions. Zimmer will provide various military and civilian agencies with orthopedic hip, knee, spine, and extremity trauma implant procedural packages, according to the DoD memo. Read more

In case you missed it

RSS From Medical Design & Outsourcing

  • COVID-19 immunity test developers at MIT seek diagnostic manufacturer
    MIT researchers have developed a device for predicting an individual’s COVID-19 immunity and are looking for a diagnostic company to get it manufactured in large numbers and approved by the FDA. The lateral flow test uses the same technology as at-home rapid antigen COVID-19 tests to measure neutralizing antibodies for SARS-CoV-2 in a blood sample,… […]
  • GE Healthcare picks AI imaging startups for inaugural Edison Accelerator
    GE Healthcare and Nex Cubed have selected seven companies focused on artificial-intelligence-augmented medical imaging for the first cohort of the Edison Accelerator in Canada. The companies will be matched with mentors and test their technologies with GE’s new Edison Digital Health Platform over the next three months. The program will end with innovation showcase presentations… […]
  • Boston Scientific whistleblower launches corruption investigation
    Boston Scientific (NYSE:BSX) is investigating claims that the company violated the U.S. Foreign Corrupt Practices Act in Vietnam. Marlborough, Massachusetts–based Boston Scientific disclosed receipt of a whistleblower’s allegations in its latest filing with the Securities and Exchange Commission. “In March 2022, the company received a whistleblower letter alleging Foreign Corrupt Practices Act violations in Vietnam.… […]
  • 5 essential leadership lessons from Cathy Burzik for medtech’s next generation of women leaders
    Cathy Burzik, a seasoned senior executive in the healthcare industry, has successfully led major medical device, diagnostic, diagnostic imaging and life sciences businesses. Cathy Burzik, CFB Interests (as told to MedExecWomen co-founder Maria Shepherd) One key to being a successful women leader in MedTech: “Play nice, but play to win.” Cathy Burzik, who received a… […]
  • Stratasys plans to buy Covestro’s additive manufacturing business
    Stratasys (Nasdaq:SSYS) said today that it has a deal to purchase the additive manufacturing materials business of Covestro. The deal includes R&D facilities and activities, global development and sales teams across Europe, the U.S. and China, a portfolio of approximately 60 additive manufacturing materials, and hundreds of patents and patents pending, Stratasys said in a… […]
  • New implant design prevents scar tissue without drugs, MIT says
    Mechanically inflating and deflating an implantable device for 10 minutes a day prevents immune cells from building the scar tissue that has been a major obstacle for artificial pancreas researchers. That’s according to new findings from a team of MIT engineers who built mechanical deflection into a two-chambered, soft polyurethane device tested on mice. By… […]
  • Blue Spark’s TempTraq catches fevers faster. Fever prediction is next.
    Blue Spark Technologies developed the first wireless continuous temperature monitor patch, TempTraq, to enable faster fever detection than standard manual readings every four hours. Westlake, Ohio-based Blue Spark is now looking at fever prediction rather than just detecting them. The R&D team is working on developing an AI neural network model built on the company’s… […]
  • Harvard researchers plan to sell at-home, PCR-grade COVID testing system
    The Harvard University researchers who developed an ultrasensitive, PCR-grade nucleic acid detection technology plan to commercialize it as a portable COVID-19 test. Harvard Medical School professor Peng Yin, who also leads the Wyss Institute for Biologically Inspired Engineering’s Molecular Robotics Initiative, founded 3EO Health to sell the device. “In order to optimize the value of… […]
  • FDA reports sterilization challenge progress as EPA takes aim at EtO emissions
    The FDA offered an update on its efforts to make medical device sterilization safer as the EPA identified 23 U.S. facilities where use of ethylene oxide (EtO) presents a risk to communities. The FDA said it is similarly concerned about unsafe EtO emissions and highlighted work with the medical device industry to reduce EtO usage… […]
  • AdvaMed defends EtO facilities on EPA’s cancer risk list
    The Advanced Medical Technology Association (AdvaMed) today reacted to the EPA’s listing of commercial sterilization facilities causing elevated risks of cancer with a defense of the facilities and a call for more research. AdvaMed CEO and President Scott Whitaker said all of the listed facilities are in compliance with regulations and warned against closures. “The… […]
  • EPA flags high-cancer-risk EtO sterilization facilities across the country
    The EPA today identified nearly two dozen U.S. cities where commercial sterilizers using ethylene oxide (EtO) contribute to an elevated cancer risk for residents of surrounding communities. EtO is used on about 20 billion medical devices each year — or about half of all sterile medical devices —  and in some cases it’s the only… […]

Leave a Reply